A prospective, single-center study conducted at Hiroshima Citizens Hospital demonstrates that transitioning from traditional bottle packaging to press-through packaging (PTP) for the antiretroviral medication bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is associated with improved patient satisfaction and shifts in daily medication management practices. B/F/TAF is a widely used single-tablet regimen for people living with HIV, and while bottle packaging has been the international standard, the shift to PTP in Japan provides a new opportunity to examine patient-centered outcomes in medication logistics.
The research team implemented a questionnaire-based design to track patient experiences before and at least three months after the transition to PTP-packaged tablets. The survey assessed several key metrics including general satisfaction with the packaging, physical medication management habits—such as the use of external containers like pill organizers—and patient perceptions regarding the portability and functionality of the new packaging design. The study involved a total of 15 participants who provided data through both the initial bottle-based and subsequent PTP-based surveys.
Quantitative data from the questionnaires indicated a marked increase in patient satisfaction following the change in packaging format. During the survey period involving bottle packaging, 33.3% of participants reported being satisfied with the storage method. In contrast, following the transition to PTP packaging, the proportion of participants reporting satisfaction rose significantly to 80.0%. This evidence suggests that the change to individual tablet casing aligns better with patient needs compared to traditional bulk bottle storage.
The study also identified measurable changes in how patients physically manage their daily medication doses. Before the transition to PTP packaging, 40.0% of the 15 participants reported transferring their tablets to an external container, such as a pill organizer. This figure decreased to 13.3% after the transition, suggesting that the convenience of the PTP design reduced the perceived need for auxiliary storage solutions. This finding highlights a potential reduction in the burden of medication logistics for patients.
Beyond the primary statistics, the researchers collected free-text responses that clarified the qualitative benefits experienced by the cohort. Participants frequently noted that the PTP format was easier to carry and allowed for more intuitive confirmation of remaining medication quantities. Additionally, the individual packaging provided specific privacy and lifestyle advantages, such as smaller printed medication names and the elimination of the noise associated with loose tablets rattling in a bottle, both of which were highlighted by participants as positive features of the PTP transition.
While the study provides evidence that PTP packaging of B/F/TAF may address portability and privacy concerns while promoting favorable changes in medication management, the authors note the limitations of the single-center, small-scale design. These findings offer preliminary insight into how packaging design can influence the daily experience of people living with HIV. Future research may be needed to determine if these management practice improvements correlate with long-term clinical adherence, but current results emphasize the significance of packaging format in the overall patient treatment experience.
The study was conducted at Hiroshima Citizens Hospital, a single-center setting where the research team administered questionnaires to participants before the packaging change and again at least three months after the transition. This prospective, questionnaire-based design allowed the investigators to compare patient experiences across two distinct periods of medication use. The primary objective was to evaluate changes in medication management practices and patient perceptions of packaging among individuals who experienced the shift from bottle-packaged to PTP-packaged B/F/TAF. By focusing on this specific transition, the researchers aimed to investigate the impact of the new packaging format on daily medication management routines.
Press-through packaging is widely used for oral medications in Japan, whereas many antiretroviral agents used internationally have traditionally been supplied in bottles. B/F/TAF was the first antiretroviral single-tablet regimen in Japan to adopt PTP packaging in addition to the traditional bottle format. This unique positioning provided a practical context for examining how changes in physical packaging might influence patient-centered outcomes. The study specifically targeted patients who had used the bottle-packaged version and then transitioned to the PTP version, ensuring that the comparison reflected a direct experience of the change in medication logistics.
The findings suggest that PTP packaging may improve patient satisfaction by addressing specific concerns regarding portability and privacy. The authors conclude that the transition to PTP packaging may be associated with favorable changes in daily medication management practices among people living with HIV. These observations highlight the potential role of packaging design in the overall treatment experience. While the study provides insight into patient perceptions and management habits, the results are based on a small cohort of 15 participants from a single institution. Therefore, the generalizability of these findings to broader populations or different healthcare settings remains limited, and the association between packaging changes and long-term clinical outcomes requires further investigation.
Subject of Research: Clinical study of HIV medication packaging transition effects on patient practices.
Article Title: Effects of the transition from bottle to PTP packaging of bictegravir/emtricitabine/tenofovir alafenamide on medication management
Article References: Sugawara, T., Suyama, Y., Miyazaki, J., Seo, K., & Watanabe, A. (2026). Effects of the transition from bottle to PTP packaging of bictegravir/emtricitabine/tenofovir alafenamide on medication management. Journal of Pharmaceutical Health Care and Sciences. https://doi.org/10.1186/s40780-026-00644-5
Image Credits: AI Generated
DOI: 10.1186/s40780-026-00644-5
Keywords: HIV, Antiretroviral therapy, B/F/TAF, Medication management, PTP packaging, Patient satisfaction, Medication adherence, Drug packaging, Portability, Privacy, Prospective study, Hiroshima Citizens Hospital, Patient perception, Pill organization, Health outcomes
News Source: Ophelia Keating. (November 18, 2026). HIV Medication Packaging Transition Improves Patient Satisfaction and Management Practices. Scienmag.



